4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000950170-25-081935
See Remarks sold 5,000 shares at an average $78.04 ($390,218)
- See Remarks acquired 5,000 shares (option exercise)
- See Remarks acquired 1,498 shares (grant or award)
- See Remarks gave up 441 shares (to pay taxes)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lyon Joseph Douglas See Remarks | 2025-06-02 | Option exercise 10b5-1 | +5,000 | $13.56 | $67,800 | 14,009 | D |
| Lyon Joseph Douglas See Remarks | 2025-06-02 | Sale 10b5-1 | −4,438 | $77.97 | $346,014 | 9,751 | D |
| Lyon Joseph Douglas See Remarks | 2025-06-02 | Sale 10b5-1 | −562 | $78.65 | $44,204 | 9,009 | D |
| Lyon Joseph Douglas See Remarks | 2025-06-02 | Grant or award 10b5-1 | +749 | $71.68 | $53,688 | 9,758 | D |
| Lyon Joseph Douglas See Remarks | 2025-06-02 | Grant or award 10b5-1 | +749 | 10,507 | D | ||
| Lyon Joseph Douglas See Remarks | 2025-06-03 | Shares withheld for taxes 10b5-1 | −441 | $71.68 | $31,611 | 10,066 | D |
| Derivatives | |||||||
| Lyon Joseph Douglas See Remarks | 2025-06-02 | Option exercise · Stock option (right to buy) 10b5-1 | −5,000 | 41,571 | D | ||
| Open-market sales · 5,000 sh · avg $78.04 · $390,218 | |||||||
Loading xslF345X05/ownership.xml…